Skånes universitetssjukhus Malmö

Running trials

• Recruiting

  A multicenter, randomized, open-label, blinded-assessor, phase 4 study in patients with early rheumatoid arthritis to compare active conventional therapy versus three biologic treatments, and two de-escalation strategies in patients who respond to treatment.

  NCT01491815· Phase 4· Source

• Not yet recruiting

  Rituximab as therapy for autoantibody mediated fibromyalgia (RAFT) - proof of concept

  2025-523465-21-00· Phase 3· Source

• Recruiting

  European Registry of Next Generation Imaging in Advanced Prostate Cancer

  NCT06866782· Source

• Active, not recruiting

  Endurant CHevAr New Indication Trial: ENCHANT

  NCT03320252· Source

• Active, not recruiting

  Safety and Efficacy Study of Enzalutamide Plus Leuprolide in Patients With Nonmetastatic Prostate Cancer (EMBARK)

  NCT02319837· Phase 3· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Fibromyalgia1 recruiting
• Prostate cancer1 recruiting
• Rheumatoid arthritis1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Completed

  Effectiveness of Treatment With Tofacitinib in Patients With Psoriatic Arthritis in Routine Clinical Practice

  NCT04517669· Source